Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Prefer paracetamol to ibuprofen to treat COVID-19 symptoms, NHS advises

There currently is no evidence which links anti-inflammatory medicines such as ibuprofen with the worsening of COVID-19, NHS said on Wednesday.

The agency, however, advised to take paracetamol to treat symptoms of COVID-19, until more information is available, adding that regulatory agencies are reviewing the evidence.


“In view of the current lack of clarity the Committee of Human Medicines (an advisory body of MHRA) and NICE have been asked to review the evidence,” said Stephen Powis, medical director at NHS England.

“It is therefore suggested that, in the interim, for patients, who have confirmed COVID-19 or believe they have COVID-19, that they use paracetamol in preference to NSAIDs (non-steroidal anti-inflammatory drugs).”

Powis added that patients already being treated with anti-inflammatory drugs for other medical reasons should not stop them.

The World Health Organization on Tuesday recommended that people suffering from COVID-19-like symptoms should avoid self-medicating with ibuprofen, after French authorities warned anti-inflammatory drugs could worsen the effects of the virus.

The warnings over the weekend by French Health Minister Olivier Veran, a clinician himself, followed a recent study in The Lancet weekly medical journal that hypothesised that an enzyme that is boosted when taking anti-inflammatory drugs like ibuprofen could facilitate and worsen COVID-19 infections.

Reckitt Benckiser (RB), the makers of Nurofen products, said it is aware of "the ongoing spread of information" concerning the use of NSAIDs including ibuprofen, but requested patients and healthcare professionals to consider each case separately.

The firm said all available treatment options, including paracetamol and NSAIDs, should be considered when starting treatment for fever or pain in COVID-19, noting that the European Medicines Agency (EMA), World Health Organisation as well as NHS has stated that there is currently no strong scientific evidence linking ibuprofen usage to worsening of COVID-19.

"Consumer safety is our number one priority. Ibuprofen is a well-established medicine that has been used with a good safety profile as a fever and pain reducer for more than 30 years," it said.

The EMA on Wednesday said that there currently is no evidence to link anti-inflammatory medicines such as ibuprofen with the worsening of COVID-19.

The EU regulator added that it was monitoring the situation, but took a similar tone to RB in suggesting patients and healthcare professionals to consider all treatment options including paracetamol and anti-inflammatory drugs to treat fever or pain in patients with COVID-19.

The COVID-19 pandemic causes mild symptoms in most people, but can result in pneumonia and in some cases severe illness that can lead to multiple organ failure.

More For You

A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less
Patients to get test results via NHS app

An investment of £50m has been made to upgrade the NHS app

Patients to get test results via NHS app

Millions of patients will now be able to access test results and get appointment reminders on their smartphones as the government tries to position the NHS app as the default mode of communication and steer away from traditional methods like letters.

An investment of £50m has been made to upgrade the NHS app and the health service hopes to save £200m over the next three years.

Keep ReadingShow less
Health minister assures House of Lords on measures to tackle UK-wide Creon drug shortage

Baroness Merron

Government taking steps to mitigate shortage of cancer drug Creon

Baroness Merron on Monday (9) assured the House of Lords that the government is taking measures to mitigate the shortage of pancreatic cancer drug Creon across the country.

Raising the issue, Baroness Margaret Ritchie wanted to know about the steps being taken by the government to ease the misery of patients suffering from pancreatic cancer.

Keep ReadingShow less
Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Janet Morrison

Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Community Pharmacy England (CPE) chief executive Janet Morrison has welcomed chancellor Rachel Reeves announcement today that day-to-day spending on the NHS will increase by £29bn a year but insisted that it must reflect in securing the future of pharmacy.

Reeves also revealed that the government will be increasing the NHS technology budget by almost 50 per cent, with £10bn of investment to "bring our analogue health system into the digital age, including through the NHS app".

Keep ReadingShow less
Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less